DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Resiquimod
Resiquimod
Newer Trends in the Management of Genital Herpes
The Effects of Atopy and Asthma on in Vivo Human Nasal Responses to Toll
Inclusion and Exclusion Criteria for Each Key Question
Bioinformatics Review of the Role of HSV-1 in Alzheimer's Disease
S1 Figa
Activation of Anti-Hepatitis C Virus Responses Via Toll-Like Receptor 7
Annual Report 2016
Naive Alum | IMQ-Cpg
Breast Cancer Treatment with Imiquimod: Applying an Old Lotion to a New Disease
Time-Resolved Effect of Interferon-Alpha 2A on Activities of Nuclear Factor Kappa B, Pregnane X Receptor and on Drug Disposition Genes
Immunosuppressant Ingredients, Immunostimulant Ingredients
Rapid Host Immune Response and Viral Dynamics in Herpes Simplex Virus-2 Infection
Wo 2010/059253 A2
I Regulations
Infection Research Reagents
Documents Numérisés Par Onetouch
Development of Resiquimod-Loaded Modified PLA-Based Nanoparticles
EDUCATION Cause
Top View
2919.Full.Pdf
Blocking Type I Interferon Signaling Enhances T Cell Recovery and Reduces HIV-1 Reservoirs
In Ovo Delivered Toll-Like Receptor 7 Ligand, Resiquimod Enhances Host Responses Against Infectious Bronchitis Corona Virus (IBV) Infection
Activation of Plasmacytoid Dendritic Cells and B Cells with Two Structurally Different Toll-Like Receptor 7 Agonists
Stembook 2018.Pdf
Toll-Like Receptors As Potential Therapeutic Targets for Multiple Diseases
R848 Vaccigrade ™ Imidazoquinoline Compound; a TLR7/8-Based Adjuvant Catalog # Vac-R848
Comparing the Immunogenicity of Glycosidase-Directed Resiquimod Prodrugs Mediated by Cancer Cell Metabolism
Learning from the Messengers: Innate Sensing of Viruses and Cytokine Regulation of Immunity—Clues for Treatments and Vaccines
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Open Full Page
WO 2017/035230 Al 2 March 2017 (02.03.2017) P O P C T
WO 2018/165198 Al 13 September 2018 (13.09.2018) W !P O PCT
Recurrent Genital Herpes Treatments and Their Impact on Quality of Life Mathijs H
9186400.Pdf (2.851Mb)
TLR7 and TLR8 As Targets in Cancer Therapy
Customs Tariff - Schedule Xxi - 1
WO 2018/144390 Al 09 August 2018 (09.08.2018) W !P O PCT
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0023746 A1
Production in Females Α TLR7 Ligands Induce Higher IFN
Therapeutic Options for Herpes Simplex Infections Eugene Au and Stephen L
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Accepted Manuscript
WO 2015/151078 A4 8 October 2015 (08.10.2015) P O P C T
Herpes Simplex Virus and Gene Therapy
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
Review Imiquimod and Resiquimod As Novel Immunomodulators
Antiviral Therapy in Chronic Hepatitis B Viral Infection During Pregnancy
TLR Agonists As Vaccine Adjuvants Targeting Cancer and Infectious Diseases
New Directions in Hepatitis B Therapy Research
Activation of the Innate Immune Response As Therapy for CTCL
Us 2019 / 0127401 A1
Supplemental Table 1: Inclusion and Exclusion Criteria
Cytokine Therapy: Lessons Learned
Bourquin, C., Hotz, C. Et. Al.: R848 Tolerance 6/23/11 1
International Nonproprietary Names for Pharmaceutical Substances (INN)